ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma
December 17, 2021The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund. -
Adjuvant RT May Cut Recurrence in Some With Prostate Cancer
August 13, 2019Adjuvant radiotherapy after radical prostatectomy compared with surgery alone may prolong biochemical recurrence-free survival in patients with locally advanced prostate cancer... -
NICE rejects adjuvant use of Perjeta post-surgery
June 21, 2018The National Institute for Health and Care Excellence says adjuvant use of Roche’s breast cancer drug Perjeta in patients who have had surgery is not cost effective for the NHS.
Pharma Sources Insight January 2025
